8-KItem 1.01 · Material AgreementItem 1.02 · Termination of AgreementItem 2.03 · Financial ObligationItem 9.01 · Financial Statements
Boston Scientific ($BSX) 8-K filed 2026-02-26: Item 2.03 confirms creation of a direct financial…
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) 8-K filed 2026-02-26: Item 2.03 confirms creation of a direct financial obligation / off‑balance‑sheet arrangement via the 2026 Credit Agreements; specifics are incorporated by reference to Item 1.01. 📄🔁 #SECfiling #corporatedebt
Note to investors: Item 2.03 does not restate amounts, lenders or terms—see Item 1.01 of the 8-K for full details on the 2026 Credit Agreements (amounts, covenants, parties). Review the filing for material financial impact. 🔎 $BSX #debt #credit